Autolus Therapeutics
AUTL
$4.39
Share price
7.86%
Change (1 day)
48.81%
Change (1 year)
Categories
P/S ratio for Autolus Therapeutics (AUTL)
P/S ratio as of May 2024 (TTM): 637
According to Autolus Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 637.408. At the end of 2023 the company had a P/S ratio of 659.
P/S ratio history for Autolus Therapeutics from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 659 | 1140.86% |
| 2022 | 53.1 | -73.78% |
| 2021 | 202 | -74.9% |
| 2020 | 807 | 254.8% |
| 2019 | 227 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |